Akums Reports Q4 FY26 and Full Year FY26 Results
Akums Drugs & Pharmaceuticals Ltd has announced its financial results for the fourth quarter and full fiscal year ending March 31, 2026. The company reported a healthy top-line performance coupled with strong EBITDA growth, underscoring its operational efficiency and market positioning.
Financial Highlights
For the quarter ended March 2026, Akums recorded a revenue of Rs 1,234 crore, reflecting a year-on-year growth of 18%. The EBITDA for Q4 stood at Rs 245 crore, marking a 22% increase compared to the same period last year. The EBITDA margin improved to 19.8%, driven by cost optimization and a favorable product mix.
On a full-year basis, the company's revenue reached Rs 4,567 crore, up 16% from FY25. Full-year EBITDA was Rs 890 crore, with a margin of 19.5%. Net profit for FY26 came in at Rs 520 crore, representing a 20% growth over the previous fiscal.
Dividend Recommendation
In a positive move for shareholders, the board of directors has recommended a dividend of Rs 5 per equity share for the fiscal year 2025-26. The dividend is subject to approval by shareholders at the upcoming annual general meeting.
Management Commentary
Commenting on the results, the Managing Director of Akums said, "We are pleased with our performance in FY26, which reflects our commitment to operational excellence and strategic growth. The strong EBITDA growth is a testament to our focus on efficiency and innovation. We remain optimistic about the future and will continue to invest in capacity expansion and new product development."
Business Outlook
Looking ahead, Akums plans to enhance its manufacturing capabilities and expand its product portfolio, particularly in the chronic and acute therapeutic segments. The company also aims to strengthen its presence in international markets, leveraging its regulatory approvals and quality certifications.
The pharmaceutical sector is expected to witness steady demand, and Akums is well-positioned to capitalize on emerging opportunities. With a robust pipeline and a focus on operational efficiencies, the company is confident of delivering sustainable growth in the coming years.
